Back Calculated Data Agree with Experimental NOESY Spectrum, Structures with Acceptable Covalent Geometry, Structures with Favorable Non-bond Energy, Structures with the Least Restraint Violations, Structures with the Lowest Energy
代表モデル
-
要素
#1: タンパク質・ペプチド
HIV-1TatPeptide
分子量: 1484.754 Da / 分子数: 1 / 由来タイプ: 合成 / 詳細: The Peptide was Chemically Synthesized. / 参照: UniProt: P04610*PLUS
0.5 mM Bromodomain (U-15N)/Tat Peptide; 100 mM Phosphate Buffer of pH 6.5, 5 mM Perdeuterated DTT and 0.5 mM EDTA
90% H2O/10% D2O
2
0.5 mM Bromodomain (U-13C,15N)/Tat Peptide; 100 mM Phosphate Buffer of pH 6.5, 5 mM Perdeuterated DTT and 0.5 mM EDTA
99.5% D2O
3
0.5 mM Bromodomain (U-13C,15N, 75%-2H)/Tat Peptide; 100 mM Phosphate Buffer of pH 6.5, 5 mM Perdeuterated DTT and 0.5 mM EDTA
90% H2O/10% D2O
試料状態
イオン強度: 100 mM / pH: 6.5 / 圧: Ambient / 温度: 303 K
結晶化
*PLUS
手法: other / 詳細: NMR
-
NMR測定
放射
プロトコル: SINGLE WAVELENGTH / 単色(M)・ラウエ(L): M
放射波長
相対比: 1
NMRスペクトロメーター
タイプ
製造業者
モデル
磁場強度 (MHz)
Spectrometer-ID
Bruker DRX
Bruker
DRX
600
1
Bruker DRX
Bruker
DRX
500
2
-
解析
NMR software
名称
バージョン
開発者
分類
NMRPipe
3
FrankDelaglio
解析
NMRView
3.5
BruceJohbson
データ解析
X-PLOR/ARIA
2
MichaelNilges
構造決定
X-PLOR 3.851
Brunger
精密化
精密化
手法: Distance Geometry, Simulated Annealing / ソフトェア番号: 1 詳細: THE ARIA/X-PLOR PLATFORM HAS BEEN USED FOR THE NOE ASSIGNMENT
NMRアンサンブル
コンフォーマー選択の基準: Back Calculated Data Agree with Experimental NOESY Spectrum, Structures with Acceptable Covalent Geometry, Structures with Favorable Non-bond Energy, Structures ...コンフォーマー選択の基準: Back Calculated Data Agree with Experimental NOESY Spectrum, Structures with Acceptable Covalent Geometry, Structures with Favorable Non-bond Energy, Structures with the Least Restraint Violations, Structures with the Lowest Energy 計算したコンフォーマーの数: 100 / 登録したコンフォーマーの数: 25